, Volume 40, Issue 1, pp 328–339

Foxp3, Regulatory T Cell, and Autoimmune Diseases


DOI: 10.1007/s10753-016-0470-8

Cite this article as:
Tao, JH., Cheng, M., Tang, JP. et al. Inflammation (2017) 40: 328. doi:10.1007/s10753-016-0470-8


Regulatory T cells (Tregs) represent a cell type that promotes immune tolerance to autologous components and maintains immune system homeostasis. The abnormal function of Tregs is relevant to the pathogenesis of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and other autoimmune diseases. Therefore, therapeutic modulation of Tregs could be a potent means of treating autoimmune diseases. Human Tregs are diverse, however, and not all of them have immunosuppressive effects. Forkhead box P3 (Foxp3), a pivotal transcription factor of Tregs that is crucial in maintaining Treg immunosuppressive function, can be expressed heterogeneously or unstably across Treg subpopulations. Insights into modulating Treg differentiation on the level of DNA transcription or protein modification may improve the success of Treg modifying immunotherapies. In this review, we will summarize three main prospects: the regulatory mechanism of Foxp3, the influence on Foxp3 and Tregs in autoimmune diseases, then finally, how Tregs can be used to treat autoimmune diseases.


regulatory T cells forkhead box P3 autoimmune diseases 

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Department of Rheumatology and ImmunologyAnhui Provincial Hospital Affiliated to Anhui Medical UniversityHefeiChina
  2. 2.Immunology and Hematopoiesis Division, Department of Oncology and MedicineJohns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations